[Cholinergic treatment strategies in Alzheimer's disease].
D000109:Acetylcholine / Q000378:metabolism; D000544:Alzheimer Disease / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects; D002794:Choline / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D011939:Mental Recall / Q000187:drug effects; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects
D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D010713:Phosphatidylcholines; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D002794:Choline; D000109:Acetylcholine; D010889:Piracetam
Cholinerge Behandlungsstrategien bei der Alzheimerschen Krankheit.